Ibandronate sodium
CAS No.
138926-19-9
Reference product
Polymorphic form
Monohydrate Form B
Therapeutic Area
Musculo-skeletal system
Status
commercial
EU DMF readiness
✓
US DMF readiness
025638
CEP
✓
Other documentation
Chinese DMF
Korean DMF
Japanese DMF
Brazilian DMF - pending
💉 Available also
in injectable form
Products protected by valid patents are not offered for commercial sale in countries where the sale of such products constitutes patent infringement but are offered solely for uses reasonably related to the development and submission of information under a law regulating the manufacture, use or sale of drugs. It is within the buyer’s responsibility and liability to check the patent situation of the product in the imported market(s).